BTBD9 Antibodies

AND BTBD9 ELISA kits, BTBD9 Proteins

Many biological assays use antibodies to detect BTBD9, such as Western Blot (WB), ELISA, Flow Cytometry, Immunocytochemistry (IHC). These antibodies can be polyclonal or monoclonal, and react with BTBD9 in Human, Mouse, Rat, and many other animal samples. Boster Bio use mainly mouse and rabbit to develop BTBD9 antibodies...

We validate the specificity of these antibodies to BTBD9 by testing them on tissues known to express BTBD9 positively and negatively. Browse below to find the BTBD9 antibody that suites your experiment. We have 2 of these antibodies and many publications and validation images.

If you cannot find antibodies that fit your needs, contact us for making custom antibodies. We have a full suite of custom antibody services covering from research to diagnostic and therapeutic applications.

Previous: Septin9 Next: CSMD2

BTBD9 Infographic by Boster Bio

All BTBD9 Products

Filter by Application:

Product

Figures

Specificity

Applications

Price

BTBD9 (NM_152733) Human Recombinant Protein

Coomassie blue staining of purified BTBD9 protein

$1062
Cat # PROTQ96Q07
20 µg

BTBD9 (NM_052893) Human Over-expression Lysate

BTBD9 Human Over-expression Lysates NM_001099272

Human

$960
Cat # LS114781
20 µg, 100 µg

BTBD9 Overview

Facts about BTB/POZ domain-containing protein 9.

BTBD9 3D structure. Source: alphafold

BTB/POZ domain-containing protein 9 (BTBD9)

Gene Information

Human
Gene Name:	BTBD9
Uniprot:	Q96Q07
Entrez:	114781

Family

Belongs to:

No superfamily

Alternative Names

BTB (POZ) domain containing 9; BTB/POZ domain-containing protein 9; FLJ32945; KIAA1880dJ322I12.1; MGC120517; MGC120519; MGC120520

Molecular Weight

Mass (kDA):
69.188 kDA

Genomic Context


Human

Location:	6p21.2
Sequence:	6; NC_000006.12 (38168451..38640541, complement)

Tissue Specificity

Detected in the brain (at protein level) (PubMed:22658601). Moderately expressed in all specific brain regions examined (PubMed:11572484). Expressed in the dopaminergic neurons of the substantia nigra and A11 neurons (PubMed:22658601). Highly expressed in kidney and moderately expressed in all other adult and fetal tissues (PubMed:11572484).

Diseases

Restless Legs Syndrome
Agitation
Nervous System Disorder
Nervousness
Iron Deficiency
Sleep Disorders
Nocturnal Myoclonus Syndrome
Polyneuropathy
Attention Deficit Hyperactivity Disorder
Gilles De La Tourette Syndrome
Movement Disorders

Sclerosis
Pregnancy Complications
Narcolepsy
Sleep Apnea Syndromes
Fragmentation, Sleep
Parkinson Disease

Pathways

Pathogenesis
Transport
Vesicle Transport
Synaptic Transmission
Endocytosis
Synaptic Vesicle Transport
Head Morphogenesis
Sensory Perception

Localization
Limb Development

For details, visit:
bosterbio.com/bosterbio-gene-info-cards/BTBD9

References

PMID: 17634447 by Stefansson H., et al. A genetic risk factor for periodic limb movements in sleep.

PMID: 18216367 by Vilarino-Guell C., et al. A genetic risk factor for periodic limb movements in sleep.